AU3158701A - New use - Google Patents

New use

Info

Publication number
AU3158701A
AU3158701A AU31587/01A AU3158701A AU3158701A AU 3158701 A AU3158701 A AU 3158701A AU 31587/01 A AU31587/01 A AU 31587/01A AU 3158701 A AU3158701 A AU 3158701A AU 3158701 A AU3158701 A AU 3158701A
Authority
AU
Australia
Prior art keywords
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31587/01A
Inventor
Colin A. Campbell
Sarah Jane Hadingham
David Charles Harrison
Guillaume Jean Hervieu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU3158701A publication Critical patent/AU3158701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU31587/01A 1999-12-16 2000-12-12 New use Abandoned AU3158701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9929772 1999-12-16
GBGB9929772.3A GB9929772D0 (en) 1999-12-16 1999-12-16 New use
PCT/EP2000/012703 WO2001043759A2 (en) 1999-12-16 2000-12-12 Use of 11cby popypeptides and polynuceotides

Publications (1)

Publication Number Publication Date
AU3158701A true AU3158701A (en) 2001-06-25

Family

ID=10866456

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31587/01A Abandoned AU3158701A (en) 1999-12-16 2000-12-12 New use

Country Status (3)

Country Link
AU (1) AU3158701A (en)
GB (1) GB9929772D0 (en)
WO (1) WO2001043759A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221613B1 (en) 1998-12-31 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
US7078187B2 (en) 2001-04-19 2006-07-18 Neurogen Corporation Melanin concentrating hormone receptors
US7078484B2 (en) 2001-04-19 2006-07-18 Neurogen Corporation Melanin concentrating hormone receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633517B2 (en) * 1988-09-13 1993-02-04 Large Scale Biology Corporation Prophylaxis and treatment of nervous system diseases with melanin
EP0848060A3 (en) * 1996-12-11 2000-02-02 Smithkline Beecham Corporation Novel human 11CB splice variant
EP1042498A4 (en) * 1997-12-03 2003-05-07 Smithkline Beecham Corp A method of finding agonist and antagonist to human 11cb splice variant
JP2002525054A (en) * 1998-09-17 2002-08-13 インサイト・ファーマスーティカルズ・インコーポレイテッド Human GPCR protein
WO2000049170A1 (en) * 1999-02-18 2000-08-24 Smithkline Beecham Corporation MURINE 11cby RECEPTOR

Also Published As

Publication number Publication date
GB9929772D0 (en) 2000-02-09
WO2001043759A2 (en) 2001-06-21
WO2001043759A3 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU4431000A (en) Novel use
AU5967600A (en) Candystraw
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU7514700A (en) Cyanopiperidines
AU2804600A (en) Arylaminoalkylamides
AU6440900A (en) Homogentisate-dioxygenase
AU2023701A (en) Sketcher
AU2699800A (en) Organoceramics
AU4916900A (en) Benzofuranylsulfonates
AU6098300A (en) Follistatin-3
AU4561600A (en) Benzofuranylaminoalcohols
AUPQ078799A0 (en) New use
AU1901801A (en) Glucofuranoses
AU2669501A (en) New use
AU1915601A (en) Periotome
AU2582200A (en) Windturbine
AU7303400A (en) Osseo-distractor
AU7513400A (en) Hydantoin-racemase
AU4435300A (en) Hula-hoop
AUPQ462399A0 (en) New use
AU3158701A (en) New use
AU2197301A (en) Microlamp

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase